BIOLEXIS
Biolexis.com is a premiere online resource for life sciences professionals, investors and entrepreneurs.
BIOLEXIS
Social Links:
Industry:
Internet
Website Url:
http://www.biolexis.com
Status:
Active
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Amazon Office 365 Mail GoDaddy DNS AWS Global Accelerator
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2018-11-05 | Outlook Therapeutics | Biolexis investment in Post-IPO Equity - Outlook Therapeutics | 20 M USD |
Official Site Inspections
http://www.biolexis.com
- Host name: 172.67.215.140
- IP address: 172.67.215.140
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Biolexis"
About – Biolexis
Dr. David J. Bearss is a trendsetting entrepreneur of drug development with over 20 years’ of experience. Not only is David an industry-leading expert in small molecule drug development …See details»
Biolexis CEO and Key Executive Team | Craft.co
Biolexis's Co-Founder and Chairman of the Board is David J. Bearss. Other executives include Hariprasad Vankayalapati, Co-Founder and Chief Scientific Officer; David Taylor, Chief …See details»
Biolexis – Lide Sciences and Biotechnology
Dec 27, 2022 Thanks to a new microscope, scientists can now take 3-D movies of molecular processes that […]See details»
Biolexis Therapeutics Company Profile | Management and
Biolexis Therapeutics Profile and History. Founded in 2021 and headquartered in American Fork, Utah, Biolexis Therapeutics is a privately held clinical-stage biopharmaceutical company …See details»
Organization ile cümleler | Bilexis
The organization's diversity and inclusion policy promotes equal opportunities. In the realm of cybersecurity, organizations need to keep a constant vigil against potential threats and …See details»
Biolexis lands $10m to advance metabolic drug program with …
Dec 5, 2023 AI-driven drug discovery company Biolexis Therapeutics has closed a $10 million Series A funding round, supporting its mission to advance metabolic drug development. The …See details»
BioLexis Reorganization Results in GMS Holdings as Largest …
On April 22, 2022 Outlook Therapeutics, Inc. (Nasdaq: OTLK), a pre-commercial biopharmaceutical company working to develop and launch the first FDA-approved ophthalmic …See details»
Biolexis - Stelis
Biolexis About Us Biolexis is an early-stage B2B biopharmaceutical company on a mission to transform the world of healthcare by developing and commercializing high quality, affordable, …See details»
Biolexis Therapeutics - Recent News & Activity - Crunchbase
Biolexis Therapeutics is a privately held biopharmaceutical company committed to developing novel targeted therapeutics.See details»
Biolexis Therapeutics | VentureRadar
Website: https://biolexistx.com/ Utilizes AI to advance metabolic drug development, focusing on age-related conditions and human longevity with a primary focus on ...See details»
Biolexis - Funding, Financials, Valuation & Investors - Crunchbase
Biolexis.com is a premiere online resource for life sciences professionals, investors and entrepreneurs.See details»
Outlook Therapeutics says BioLexis reorganization results in GMS ...
Apr 22, 2022 Outlook Therapeutics (NASDAQ:OTLK) Inc revealed that BioLexis Private Limited, a strategic shareholder in the pre-commercial biopharmaceutical company, is being …See details»
BioLexis Portfolio Investments, BioLexis Funds, BioLexis Exits
Oct 29, 2024 BioLexis is a Singapore-based joint-venture between Tenshi Life Sciences Private Limited, and GMS Holdings, a private investment company. Use the CB Insights Platform to …See details»
Biolexis Unveils Promising Data with an Oral Weight Loss Drug: …
Dr. David J. Bearss is a trendsetting entrepreneur of drug development with over 20 years’ of experience. Not only is David an industry-leading expert in small molecule drug development …See details»
Collocations with need | Bilexis Dictionary
・The organization provides financial aid to families in immediate need. considerable, great, strong ・The community has a considerable need for affordable housing. overriding, …See details»
Biolexis Secures $10 Million in Series A Funding to Advance …
Led by Clarke Capital, the New Funding Round Will Accelerate the Company’s Drug Discovery Pipeline. American Fork, UT – November 29, 2023. Biolexis, Inc., a clinical stage AI-driven …See details»
Collocations with charity | Bilexis Dictionary
・The organization is launching a charity appeal for a new air ambulance. shop ・I usually give all our old clothes to the charity shop. event ・She spoke at a charity event in aid of famine relief. …See details»
Collocations with body | Bilexis Dictionary
2-) an organization ADJECTIVES & NOUNS . public ・The water and electricity supplies are controlled by public bodies. national • international ・The World Bank and other international …See details»
Collocations with trust | Bilexis Dictionary
・The organization deserves complete trust. basic • mutual • sacred ・The sacred trust has been passed down through generations. fragile ・The relationship was based on fragile trust. …See details»
Collocations with image | Bilexis Dictionary
1-) the way a person, organization etc seems to the public ADJECTIVES. good, positive ・It is important to present a positive image of yourself at the interview. bad, negative, poor ・It’s …See details»